NEW YORK, March 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Read More Details
Finally We wish PressBee provided you with enough information of ( INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT )
Also on site :
- Former Microsoft engineer fired over protest on Israel AI ties
- 'The Office' Star, 45, Wants to Be in Upcoming Spin-Off Series
- Sputnik V creator warns of global ‘cat flu’ pandemic